Bivalirudin for Injection 250 mg

Bivalirudin for Injection 250 mg is a powder for solution used for anticoagulation. This medication is administered intravenously and is manufactured by Formative Pharma Inc. in Canada.

Bivalirudin for Injection 250 mg is generally used for anticoagulation purposes. It is often utilized in procedures where blood clotting needs to be controlled, such as during certain medical interventions. The primary use of bivalirudin is to prevent blood clots from forming in the blood vessels. It is important to consult with a healthcare provider to understand the specific uses of this medication.

Bivalirudin for Injection 250 mg works by inhibiting the action of thrombin, an enzyme that plays a crucial role in blood clotting. This can help to prevent the formation of blood clots. Common effects may include changes in blood pressure and heart rate, as well as potential bleeding at the injection site. Always monitor for any unusual symptoms and consult a healthcare provider if necessary.

Bivalirudin for Injection 250 mg should be handled with care. It is important to follow proper administration procedures to avoid complications. Patients with a history of bleeding disorders or those taking other anticoagulants should use this medication with caution. Always store the medication as directed and ensure it is used within its expiration date.

Bivalirudin for Injection 250 mg may interact with other medications, particularly those that affect blood clotting. This includes other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should also be avoided as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.